Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.080
-0.030 (-1.42%)
At close: Sep 15, 2025, 4:00 PM EDT
2.080
0.00 (0.00%)
After-hours: Sep 15, 2025, 7:58 PM EDT
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $100.48 million as of September 15, 2025. Its market cap has decreased by -92.16% in one year.
Market Cap
100.48M
Enterprise Value
-11.90M
1-Year Change
-92.16%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $100.48M, a decrease of -52.73%. That is a compound annual growth rate of -2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 100.48M | -11.50% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | 238.38M | 166.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |